Bio-Connect
IHC-P analysis of B cell chronic lymphocytic leukemia tissue using GTX01886 Human lambda Light chain antibody [SHL53]. Note the neoplastic cells show a moderate and distinct predominantly membrane staining reaction.
IHC-P analysis of B cell chronic lymphocytic leukemia tissue using GTX01886 Human lambda Light chain antibody [SHL53]. Note the neoplastic cells show a moderate and distinct predominantly membrane staining reaction.
IHC-P analysis of B cell chronic lymphocytic leukemia tissue using GTX01886 Human lambda Light chain antibody [SHL53]. Note the neoplastic cells show a moderate and distinct predominantly membrane staining reaction.

Human lambda Light chain antibody [SHL53]

Research Use Only
GTX01886
GeneTex
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetIGL
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Human lambda Light chain antibody [SHL53]
  • Delivery Days Customer
    9
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    SHL53
  • Conjugate
    Unconjugated
  • Gene ID3535
  • Target name
    IGL
  • Target description
    immunoglobulin lambda locus
  • Target synonyms
    ig lambda-6 chain C region; IGL@; IGLC6; immunoglobulin lambda gene cluster
  • Host
    Mouse
  • Isotype
    IgG1
  • Scientific Description
    Immunoglobulins recognize foreign antigens and initiate immune responses such as phagocytosis and the complement system. Each immunoglobulin molecule consists of two identical heavy chains and two identical light chains. There are two classes of light chains, kappa and lambda. This region represents the germline organization of the lambda light chain locus. The locus includes V (variable), J (joining), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a single V segment with a J segment; the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. Several V segments and three C segments are known to be incapable of encoding a protein and are considered pseudogenes. The locus also includes several non-immunoglobulin genes, many of which are pseudogenes or are predicted by automated computational analysis or homology to other species. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203